EUVIMEDDécouvrir EUVIMED
CrossrefCarte d’information

Multitarget Regulatory Mechanisms and Research Advances of Plant‐Derived Bioactive Ingredients in Hypertension Prevention and Management

Qiqi Deng, Yonglin Zhang, Jing Pan, Jing Luo, Hualin Sun, Chaonian Li, Li Li

Phytotherapy Research · 2026-11 · 40 (11) · 6173-6200

DOI: 10.1002/ptr.70428 ↗
RésuméRéférences bibliographiques

Résumé

ABSTRACT Hypertension remains a major global risk factor for cardiovascular diseases, yet current treatments face challenges such as suboptimal blood pressure control and inadequate organ protection. Plant‐derived bioactive ingredients (PDBIs), with their multi‐target and multi‐pathway properties, offer novel strategies for hypertension management. This review systematically examines the mechanisms of major PDBIs (flavonoids, terpenoids, alkaloids) in hypertension, focusing on their regulation of vascular function, renin‐angiotensin‐aldosterone system and sympathetic nervous system, water‐salt homeostasis, and target organ protection. Key signaling pathways involved (NF‐κB, TGF‐β, MAPK, PI3K/Akt) are analyzed. Clinical translation challenges, including low bioavailability and response heterogeneity, are discussed. Future research should integrate systems pharmacology, smart delivery systems, and precision medicine to advance PDBIs from traditional use to evidence‐based therapy, providing a theoretical basis for developing novel antihypertensive and organ‐protective strategies.

Des connaissances adaptées à votre travail.

D’un démarrage gratuit à la Research Suite complète, en passant par la recherche bibliographique personnelle.

Voir les tarifs →

Tous les textes intégraux sont-ils inclus ?

Non. Notices, résumés et textes intégraux sont des contenus distincts. La disponibilité dépend de la source, de l’accès ouvert et de vos licences. Une offre EUVIMED ne remplace pas des droits supplémentaires auprès des éditeurs.

Voir les tarifs →